GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Cyclically Adjusted FCF per Share

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Cyclically Adjusted FCF per Share : $0.92 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Takeda Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Dec. 2023 was $0.151. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.92 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Takeda Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was -2.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Takeda Pharmaceutical Co was 13.20% per year. The lowest was 3.20% per year. And the median was 7.10% per year.

As of today (2024-04-27), Takeda Pharmaceutical Co's current stock price is $13.03. Takeda Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $0.92. Takeda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 14.16.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Takeda Pharmaceutical Co was 39.61. The lowest was 14.00. And the median was 20.78.


Takeda Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Takeda Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.80 0.92 1.01 0.95

Takeda Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 0.95 0.89 0.86 0.92

Competitive Comparison of Takeda Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Takeda Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Takeda Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.151/106.8000*106.8000
=0.151

Current CPI (Dec. 2023) = 106.8000.

Takeda Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.513 95.700 0.573
201406 -0.174 98.000 -0.190
201409 0.316 98.500 0.343
201412 0.203 97.900 0.221
201503 0.053 97.900 0.058
201506 0.016 98.400 0.017
201509 0.277 98.500 0.300
201512 0.282 98.100 0.307
201603 -0.956 97.900 -1.043
201606 0.220 98.100 0.240
201609 0.240 98.000 0.262
201612 -0.061 98.400 -0.066
201703 0.482 98.100 0.525
201706 0.269 98.500 0.292
201709 0.212 98.800 0.229
201712 0.367 99.400 0.394
201803 0.601 99.200 0.647
201806 0.030 99.200 0.032
201809 0.307 99.900 0.328
201812 0.351 99.700 0.376
201903 0.211 99.700 0.226
201906 0.231 99.800 0.247
201909 0.556 100.100 0.593
201912 0.191 100.500 0.203
202003 0.362 100.300 0.385
202006 0.313 99.900 0.335
202009 0.619 99.900 0.662
202012 0.533 99.300 0.573
202103 0.844 99.900 0.902
202106 0.364 99.500 0.391
202109 0.545 100.100 0.581
202112 0.834 100.100 0.890
202203 0.866 101.100 0.915
202206 -0.034 101.800 -0.036
202209 0.403 103.100 0.417
202212 0.773 104.100 0.793
202303 -0.355 104.400 -0.363
202306 -0.400 105.200 -0.406
202309 0.278 106.200 0.280
202312 0.151 106.800 0.151

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Takeda Pharmaceutical Co  (NYSE:TAK) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Takeda Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=13.03/0.92
=14.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Takeda Pharmaceutical Co was 39.61. The lowest was 14.00. And the median was 20.78.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Takeda Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Headlines

From GuruFocus